glutamic acid has been researched along with Glaucoma in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (10.29) | 18.2507 |
2000's | 34 (50.00) | 29.6817 |
2010's | 16 (23.53) | 24.3611 |
2020's | 11 (16.18) | 2.80 |
Authors | Studies |
---|---|
Abd Ghapor, AA; Agarwal, R; Hann Yih, T; Iezhitsa, I; Mohd Ismail, N; Razali, N | 1 |
Brahma, MM; Goshima, Y; Harada, T; Namekata, K; Ohshima, T; Takahashi, K | 1 |
Dai, Y; Liu, H; Zhang, R; Zhuang, D | 1 |
Li, H; Rong, R; Xia, X; You, M; Zeng, Z | 1 |
Huang, JF; Liao, LS; Liu, SM; Wang, SC | 1 |
Ji, D; Li, H; Liu, M; Xia, X; Yang, R | 1 |
An, Y; Ding, L; Li, H; Song, S; Wang, C; Xia, X; Xia, Z; Zhou, X | 1 |
A, L; Chen, S; Gao, H; Xie, J; Xu, H; Yin, ZQ | 1 |
Bang, JW; Chan, KC; Parra, C; Schuman, JS; Wollstein, G; Yu, K | 1 |
Londhe, VY; Sharma, S; Yadav, KS | 1 |
Koizumi, S; Shinozaki, Y | 1 |
Guo, L; Huang, P; Huang, S; Lin, Z; Shen, X; Xie, B; Xu, X; Zhong, Y | 1 |
Choi, SJ; Jo, H; Jung, SH | 1 |
Mykheĭtseva, IM | 1 |
Ju, WK; Kim, H; Kim, KY; Kim, SY; Lee, D; Noh, YH; Shim, MS; Weinreb, RN | 1 |
Czeizel, E; Kádasi, ĽL; Vogt, G | 1 |
Xiong, S; Xu, X | 1 |
Chen, JY; Chen, XY; Gao, F; Gao, FJ; Luo, Y; Nickerson, JM; Sun, XH; Sun, Z; Wang, Y; Wu, JH; Zhang, SH; Zhang, SJ | 1 |
Ellisman, MH; Hoshijima, M; Ju, WK; Kim, KY; Lukas, TJ; Noh, YH; Perkins, GA; Weinreb, RN | 1 |
Aida, T; Harada, T; Namekata, K; Shinagawa, R; Takeda, T; Tanaka, K; Yanagisawa, M | 1 |
Jung, KI; Kim, JH; Park, CK | 1 |
Dada, T; Faiq, MA | 1 |
London, A; Schwartz, M | 1 |
Cordeiro, MF; Guo, L | 1 |
Bagetta, G; Cavaliere, F; Cerulli, A; Corasaniti, MT; Fazzi, E; Gliozzi, M; Morrone, LA; Nucci, C; Rombolà, L; Russo, R | 1 |
Bagetta, G; Cavaliere, F; Corasaniti, MT; Morrone, LA; Nucci, C; Russo, R; Sakurada, S; Watanabe, C | 1 |
Charalambous, P; Schallenberg, M; Thanos, S | 1 |
Bagetta, G; Bucci, MG; Corasaniti, MT; Morrone, LA; Nucci, C; Rotiroti, D; Russo, R; Tassorelli, C | 1 |
Fuse, N; Guo, X; Harada, C; Harada, T; Kikushima, K; Kimura, A; Kohyama, K; Matsumoto, Y; Mitamura, Y; Namekata, K; Tanaka, K | 1 |
Belforte, NA; Chianelli, MS; de Zavalía, N; Keller Sarmiento, MI; Moreno, MC; Rosenstein, RE; Sande, PH | 1 |
Pinar-Sueiro, S; Rodríguez-Puertas, R; Vecino, E | 1 |
Chader, GJ | 1 |
Fu, CT; Sretavan, DW | 1 |
Ishii, K; Mori, A; Nakahara, T; Sakamoto, K; Tsuda, Y; Ueda, K | 1 |
Goto, W; Hara, H; Kawazu, K; Miyawaki, N; Morikawa, N; Ota, T; Otori, Y; Tano, Y | 1 |
Roque, RS; Srinivasan, B; Taylor, S; Wordinger, RJ | 1 |
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
Amara, SG; Coimbra, NC; Coutinho-Netto, J; de Oliveira Beleboni, R; dos Santos, WF; Fontana, AC; Guizzo, R; Meirelles E Silva, AR | 1 |
Ruiz, G; Wijono, M; Woldemussie, E | 1 |
Dubielzig, RR; Gionfriddo, JR; Madl, JE; McIlnay, TR; Powell, CC | 1 |
Chun, T; Hare, WA; Lai, RK; Ruiz, G; Ton, H; Wheeler, L; WoldeMussie, E | 1 |
Clark, AF; Li, B; Pang, IH | 1 |
Case, GL; Dahl, DB; Gabelt, BT; Hernandez, MR; Kaufman, PL; May, CA; Sherwood, RW; Wamsley, S | 1 |
Lotery, AJ | 1 |
de Zavalía, N; Keller Sarmiento, MI; Marcos, HA; Moreno, MC; Rosenstein, RE; Sande, P | 1 |
Gionfriddo, JR; Madl, JE; McIlnay, TR; Powell, CC | 1 |
Cordeiro, MF; Salt, TE | 1 |
Baldridge, WH; Chauhan, BC; Hartwick, AT; Zhang, X | 1 |
Ikeda, T; Oku, H; Okuno, T; Sugiyama, T | 1 |
Cordeiro, MF; Fitzke, FW; Guo, L; Luong, V; Maass, A; Moss, SE; Salt, TE | 1 |
Gionfriddo, JR; Low, HC; Madl, JE | 1 |
Macnab, L; Pow, DV; Ruiz, G; Sullivan, RK; Woldemussie, E | 1 |
Leung, CK; Pang, CP; Zhong, YS | 1 |
Fan, SS; Huang, SY; Lai, CC; Lee Chao, PD; Lin, HJ; Tsai, FJ; Tsai, Y; Wan, L | 1 |
Aihara, M; Harada, C; Harada, T; Mitani, A; Nakamura, K; Namekata, K; Okumura, A; Quah, HM; Saeki, T; Tanaka, K; Yoshida, H | 1 |
Chen, HZ; Cui, YY; Qi, H; Ren, QS; Wang, H; Zhou, W; Zhu, L; Zhu, X | 1 |
Dreyer, EB; Lipton, SA; Podos, SM; Schumer, RA; Zurakowski, D | 1 |
Bonne, C; Muller, A; Villain, M | 1 |
Dreyer, EB | 1 |
Alvarez, A; Esquivel, F; Franco-Bourland, RE; García, GA; Guízar-Sahagún, G; Odor-Morales, A; Rodríguez, S | 1 |
Bae, JH; Chidlow, G; Melena, J; Nash, MS; Osborne, NN; Wood, JP | 1 |
Dreyer, EB; Gorla, MS; Vorwerk, CK | 1 |
Dreyer, EB; Naskar, R; Vorwerk, CK | 1 |
Ritch, R | 1 |
Agarwal, N; Agarwal, P; Clark, AF; Krishnamoorthy, RR; Lambert, W; Pang, IH; Prasanna, G; Shade, D; Sheedlo, HJ; Vopat, K; Wordinger, RJ; Yorio, T | 1 |
Kipnis, J; Ruiz, G; Schori, H; Schwartz, M; Wheeler, LA; WoldeMussie, E; Yoles, E | 1 |
Hartwick, AT | 1 |
Dalton, R | 1 |
16 review(s) available for glutamic acid and Glaucoma
Article | Year |
---|---|
Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma.
Topics: Animals; Genetic Therapy; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Neuroprotection; Neuroprotective Agents; Retinal Ganglion Cells | 2020 |
Potential roles of astrocytes and Müller cells in the pathogenesis of glaucoma.
Topics: Astrocytes; Complement C3; Ependymoglial Cells; Glaucoma; Gliosis; Glutamic Acid; Humans; Intraocular Pressure; Nerve Growth Factors; Optic Disk; Retina; Risk Factors; STAT3 Transcription Factor | 2021 |
[The option of neuroprotective therapeutics for glaucoma].
Topics: Apoptosis; Drug Interactions; Glaucoma; Glutamic Acid; Humans; Nerve Growth Factors; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells | 2014 |
Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent.
Topics: Amyloid; Animals; Brain; Diabetes Mellitus; Glaucoma; Glutamic Acid; Humans; Inflammation; Insulin; Insulin Antagonists; Mitochondria; Organ Specificity; Oxidative Stress; Protein Binding; Signal Transduction; tau Proteins | 2017 |
Assessment of neuroprotection in the retina with DARC.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Clinical Trials as Topic; Disease Models, Animal; Glaucoma; Glutamic Acid; Humans; Lasers; Neuroprotective Agents; Ophthalmoscopes; Ophthalmoscopy; Retinal Ganglion Cells; Ubiquinone; Visual Field Tests; Visual Fields; Vitamins | 2008 |
Identification of novel pharmacological targets to minimize excitotoxic retinal damage.
Topics: Animals; Cell Death; Drug Delivery Systems; Glaucoma; Glutamic Acid; Nerve Growth Factors; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Retinal Ganglion Cells | 2009 |
[Cannabinoid applications in glaucoma].
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Cannabinoids; Drug Administration Routes; Drug Evaluation, Preclinical; Endocannabinoids; Excitatory Amino Acid Antagonists; Eye Proteins; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Mammals; Morpholines; Naphthalenes; Neuroprotective Agents; Optic Nerve; Polyunsaturated Alkamides; Receptors, Cannabinoid; Retinal Ganglion Cells; Vasodilator Agents | 2011 |
[The pathogenesis of retinal ganglia cell apoptosis induced by glaucoma].
Topics: Apoptosis; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Retinal Ganglion Cells | 2004 |
Glial cells and glaucomatous neuropathy.
Topics: Apoptosis; Extracellular Matrix Proteins; Glaucoma; Glutamic Acid; Humans; Neuroglia; Nitric Oxide Synthase; Optic Nerve; Optic Nerve Diseases; Retinal Ganglion Cells; Tumor Necrosis Factor-alpha | 2007 |
[The excito-toxicity theory of glaucomatous neuropathy. General review].
Topics: Apoptosis; Glaucoma; Glutamic Acid; Humans; Neurons; Neurotransmitter Agents; Retina | 1996 |
A proposed role for excitotoxicity in glaucoma.
Topics: Animals; Glaucoma; Glutamic Acid; Humans; N-Methylaspartate; Retinal Ganglion Cells; Vitreous Body | 1998 |
Ganglion cell death in glaucoma: what do we really know?
Topics: Apoptosis; Axons; Cell Death; Ganglia, Sensory; Glaucoma; Glutamic Acid; Humans; Receptors, Cell Surface; Retinal Degeneration; Vitreous Body | 1999 |
An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide Synthase; Optic Nerve Diseases; Retinal Ganglion Cells; Vitreous Body | 1999 |
Saving the nerve from glaucoma: memantine to caspaces.
Topics: Animals; Apoptosis; Caspase Inhibitors; Caspases; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Humans; Memantine; Nitric Oxide Synthase; Optic Nerve Diseases; Retinal Ganglion Cells | 1999 |
Neuroprotection: is it already applicable to glaucoma therapy?
Topics: Animals; Apoptosis; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Neuroprotective Agents; Nitric Oxide Synthase; Optic Nerve; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells | 2000 |
Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Free Radicals; Glaucoma; Glutamic Acid; Humans; Nerve Growth Factors; Neuroprotective Agents; Nitric Oxide | 2001 |
52 other study(ies) available for glutamic acid and Glaucoma
Article | Year |
---|---|
Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury.
Topics: Amino Acid Transport System X-AG; Animals; Eye Injuries; Glaucoma; Glutamic Acid; Rats; Resveratrol; Retinal Diseases; Retinal Ganglion Cells | 2022 |
Genetic inhibition of collapsin response mediator protein-2 phosphorylation ameliorates retinal ganglion cell death in normal-tension glaucoma models.
Topics: Animals; Disease Models, Animal; Glaucoma; Glutamic Acid; Intercellular Signaling Peptides and Proteins; Mice; N-Methylaspartate; Nerve Tissue Proteins; Phosphorylation; Retinal Ganglion Cells | 2022 |
A Small Natural Molecule S3 Protects Retinal Ganglion Cells and Promotes Parkin-Mediated Mitophagy against Excitotoxicity.
Topics: Glaucoma; Glutamic Acid; Humans; Mitochondrial Proteins; Mitophagy; Neuroprotective Agents; Neurotoxins; Optic Nerve Diseases; Retinal Ganglion Cells; Thiolester Hydrolases; Ubiquitin-Protein Ligases | 2022 |
Dephosphorylation of ERK1/2 and DRP1 S585 regulates mitochondrial dynamics in glutamate toxicity of retinal neurons in vitro.
Topics: Animals; Dynamins; Glaucoma; Glutamic Acid; MAP Kinase Signaling System; Mitochondrial Dynamics; Rats; Retinal Neurons | 2022 |
Role of CAST-Drp1 Pathway in Retinal Neuron-Regulated Necrosis in Experimental Glaucoma.
Topics: Animals; Calpain; Dynamins; Glaucoma; Glutamic Acid; Necrosis; Rats; Retinal Neurons | 2023 |
GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
Topics: Animals; Apoptosis; Caspase 1; Eosine Yellowish-(YS); Glaucoma; Glutamic Acid; Glutathione; Hematoxylin; Inflammasomes; Interleukin-1beta; Lactate Dehydrogenases; Mice; N-Methylaspartate; Necroptosis; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Retinal Ganglion Cells | 2022 |
The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells.
Topics: Animals; Glaucoma; Glutamic Acid; Melatonin; Mice; N-Methylaspartate; Neuroprotective Agents; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells | 2022 |
Transplanted OECs Protect Visual Function by Regulating the Glutamate Metabolic Microenvironment in the Glaucoma Model.
Topics: Animals; Apoptosis; Glaucoma; Glutamic Acid; Rats; Rats, Long-Evans; Retinal Ganglion Cells | 2023 |
GABA decrease is associated with degraded neural specificity in the visual cortex of glaucoma patients.
Topics: Aged; Cognition; gamma-Aminobutyric Acid; Glaucoma; Glutamic Acid; Humans; Neurodegenerative Diseases; Visual Cortex | 2023 |
Effect of Adenosine and Adenosine Receptor Antagonists on Retinal Müller Cell Inwardly Rectifying Potassium Channels under Exogenous Glutamate Stimulation.
Topics: Adenosine; Animals; Ependymoglial Cells; Glaucoma; Glutamic Acid; Neuroglia; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Retina | 2018 |
Protective effects of a compound isolated from Alnus japonica on oxidative stress-induced death in transformed retinal ganglion cells.
Topics: Alnus; Animals; Apoptosis; Buthionine Sulfoximine; Catechols; Cell Survival; Diarylheptanoids; DNA Nucleotidylexotransferase; Glaucoma; Glutamic Acid; In Situ Nick-End Labeling; Lipid Peroxidation; Male; N-Methylaspartate; Neuroprotective Agents; Nitroprusside; Oxidative Stress; Plant Extracts; Propidium; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Thiobarbituric Acid Reactive Substances | 2013 |
[Protective action of melatonin in experimental glaucoma in rats].
Topics: Animals; Antioxidants; Aspartic Acid; Chromatography, Ion Exchange; Epinephrine; gamma-Aminobutyric Acid; Glaucoma; Glutamic Acid; Glycine; Intraocular Pressure; Male; Melatonin; Neuroprotective Agents; Neurotransmitter Agents; Rats; Retina; Vitreous Body | 2013 |
Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma.
Topics: Animals; Axons; bcl-Associated Death Protein; Blotting, Western; Disease Models, Animal; Female; Glaucoma; Glial Fibrillary Acidic Protein; Glutamic Acid; Heme Oxygenase-1; In Situ Nick-End Labeling; Membrane Proteins; Mice; Mice, Inbred DBA; Mitochondria; Nerve Tissue Proteins; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; Retinal Degeneration; Retinal Ganglion Cells; Superoxide Dismutase; Ubiquinone; Vitamins | 2014 |
[Homozygous E387K (1159G>A) mutation of the CYP1B1 gene in a Roma boy affected with primary congenital glaucoma. Case report].
Topics: Aryl Hydrocarbon Hydroxylases; Child, Preschool; Cytochrome P-450 CYP1B1; Genetic Counseling; Glaucoma; Glutamic Acid; Humans; Hungary; Lysine; Male; Mutation; Roma; Slovakia | 2014 |
Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma.
Topics: Animals; Apoptosis; Axons; Cell Survival; Disease Models, Animal; Disease Progression; DNA Damage; DNA Repair; DNA, Mitochondrial; Glaucoma; Glutamic Acid; Intraocular Pressure; Male; Mitochondria; Mutation; Optic Nerve; Rats, Wistar; Retinal Ganglion Cells; Time Factors | 2015 |
Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes.
Topics: Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Animals; Astrocytes; Cell Count; Cells, Cultured; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Mitochondria; Mitochondrial Dynamics; N-Methylaspartate; Optic Disk; Oxidoreductases Acting on CH-NH Group Donors; Retinal Ganglion Cells | 2015 |
Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
Topics: Animals; Caprylates; Cell Death; Excitatory Amino Acid Transporter 1; Gene Expression Regulation; Glaucoma; Glioblastoma; Glutamic Acid; Humans; Mice; Nerve Degeneration; Optic Nerve; Retinal Ganglion Cells | 2015 |
α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Biological Transport; Brimonidine Tartrate; Chronic Disease; Excitatory Amino Acid Transporter 1; Glaucoma; Glial Fibrillary Acidic Protein; Glutamic Acid; Intraocular Pressure; Male; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Glutamate | 2015 |
Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
Topics: Antigens; Calcium; Free Radicals; Glaucoma; Glutamic Acid; Humans; Intercellular Signaling Peptides and Proteins; Intraocular Pressure; Neuroprotective Agents; Optic Nerve Diseases; Oxidative Stress; Retinal Ganglion Cells; Risk Factors | 2008 |
Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
Topics: Animals; Calpain; Cell Death; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; Neuroprotective Agents; Oxidative Stress; Rats; Reperfusion Injury; Retina; Retinal Ganglion Cells; Ubiquinone | 2008 |
17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat.
Topics: Animals; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Glaucoma; Glutamic Acid; Intraocular Pressure; Male; Neurons; Rats; Rats, Wistar; Retinal Ganglion Cells | 2008 |
GM-CSF regulates the ERK1/2 pathways and protects injured retinal ganglion cells from induced death.
Topics: Adult; Aged; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Butadienes; Cells, Cultured; Disease Models, Animal; Glaucoma; Glutamic Acid; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxylamines; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuroanatomical Tract-Tracing Techniques; Nitriles; Nitro Compounds; Optic Nerve Injuries; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Retinal Ganglion Cells; Staurosporine | 2009 |
Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1-deficient mice.
Topics: Animals; Cell Death; Cell Survival; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 3; Glaucoma; Glutamic Acid; Interleukin-1; Intracellular Space; Intraocular Pressure; Mice; Mice, Knockout; Neuroglia; Retina; Retinal Degeneration; Retinal Ganglion Cells; Sodium | 2009 |
Melatonin: a novel neuroprotectant for the treatment of glaucoma.
Topics: Animals; Arginine; gamma-Aminobutyric Acid; Glaucoma; Glutamate Decarboxylase; Glutamic Acid; Histocytochemistry; Intraocular Pressure; Kinetics; Male; Melatonin; Neuroprotective Agents; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells | 2010 |
Advances in glaucoma treatment and management: neurotrophic agents.
Topics: Animals; Antioxidants; Apoptosis; Calcium Channel Blockers; Free Radicals; Glaucoma; Gliosis; Glutamic Acid; Humans; Nerve Growth Factors; Neuroprotective Agents; Nitric Oxide | 2012 |
Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma.
Topics: Animals; Axons; Disease Models, Animal; Exocytosis; Glaucoma; Glutamic Acid; Intraocular Pressure; Mice; Optic Disk; Retinal Ganglion Cells; Secretory Vesicles; Synapses; Synaptophysin; Vesicular Glutamate Transport Protein 2 | 2012 |
Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats.
Topics: Animals; Basement Membrane; Benzamidines; Capillaries; Diabetic Neuropathies; Excitatory Amino Acid Agonists; Glaucoma; Glutamic Acid; Guanidines; Intravitreal Injections; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Neurons; Retinal Vessels; Serine Proteinase Inhibitors; Severity of Illness Index; Vascular Diseases | 2012 |
Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina.
Topics: Action Potentials; Acute Disease; Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Excitatory Amino Acid Antagonists; Fetus; Glaucoma; Glutamic Acid; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Retinal Degeneration; Retinal Ganglion Cells; Timolol | 2002 |
Glutamate stimulates neurotrophin expression in cultured Müller cells.
Topics: Amino Acid Transport System X-AG; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Glaucoma; Glial Cell Line-Derived Neurotrophic Factor; Glutamic Acid; Models, Biological; Nerve Growth Factor; Nerve Growth Factors; Neuroglia; Neurotoxins; Neurotrophin 3; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Glutamate; Retina; Tetrazolium Salts; Up-Regulation | 2003 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |
Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake.
Topics: Animals; Brazil; Carbon Isotopes; Cerebral Cortex; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Disease Models, Animal; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glaucoma; Glutamic Acid; Ion Channels; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Retina; Spider Venoms; Spiders; Synaptosomes; Tissue Extracts; Tritium | 2003 |
Müller cell response to laser-induced increase in intraocular pressure in rats.
Topics: Amino Acid Transport System X-AG; Animals; Cell Count; Disease Models, Animal; Down-Regulation; Glaucoma; Glial Fibrillary Acidic Protein; Glutamate-Ammonia Ligase; Glutamic Acid; Homeostasis; Intraocular Pressure; Lasers; Male; Neuroglia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reaction Time; Retina; Retinal Degeneration; Retinal Ganglion Cells | 2004 |
Evaluation of glutamate loss from damaged retinal cells of dogs with primary glaucoma.
Topics: Analysis of Variance; Animals; Dog Diseases; Dogs; Glaucoma; Glutamic Acid; Immunohistochemistry; In Situ Nick-End Labeling; Retina | 2004 |
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
Topics: Administration, Oral; Animals; Cell Count; Chronic Disease; Disease Models, Animal; Electroretinography; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Intraocular Pressure; Macaca fascicularis; Memantine; Ocular Hypertension; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Safety; Treatment Outcome; Vitreous Body | 2004 |
Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma.
Topics: Animals; Axons; Cell Count; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Female; Glaucoma; Glutamic Acid; Intraocular Pressure; Laser Therapy; Macaca fascicularis; Macaca mulatta; Male; Optic Nerve; Optic Nerve Diseases; Trabecular Meshwork; Vitreous Body | 2005 |
Glutamate excitotoxicity in glaucoma: truth or fiction?
Topics: Animals; Glaucoma; Glutamic Acid; Haplorhini; Humans; Mice; Receptors, N-Methyl-D-Aspartate; Retinal Artery Occlusion; Retinal Ganglion Cells | 2005 |
Effect of glaucoma on the retinal glutamate/glutamine cycle activity.
Topics: Animals; Glaucoma; Glutamate-Ammonia Ligase; Glutamic Acid; Glutaminase; Glutamine; Hyaluronic Acid; Intraocular Pressure; Male; Melatonin; Rats; Rats, Wistar; Retina | 2005 |
Depletion of taurine and glutamate from damaged photoreceptors in the retinas of dogs with primary glaucoma.
Topics: Animals; Dog Diseases; Dogs; Glaucoma; Glutamic Acid; Photoreceptor Cells; Retina; Taurine | 2005 |
Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater?
Topics: Glaucoma; Glutamic Acid; Humans; Receptors, N-Methyl-D-Aspartate; Vitreous Body | 2006 |
Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging.
Topics: Animals; Animals, Newborn; Aspartic Acid; Calcium; Cells, Cultured; Diagnostic Imaging; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fura-2; Glaucoma; Glutamic Acid; In Vitro Techniques; Intraocular Pressure; Male; N-Methylaspartate; Optic Nerve; Rats; Rats, Long-Evans; Retina; Retinal Ganglion Cells; Time Factors | 2005 |
Glutamate level in optic nerve head is increased by artificial elevation of intraocular pressure in rabbits.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Glaucoma; Glutamic Acid; Microdialysis; Ocular Hypertension; Optic Disk; Rabbits | 2006 |
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Intraocular Pressure; Male; Neuroprotective Agents; Ocular Hypertension; Piperidines; Rats; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells; Staurosporine | 2006 |
Assessment of glutamate loss from the ganglion cell layer of young DBA/2J mice with glaucoma.
Topics: Aging; Animals; Glaucoma; Glutamic Acid; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Retinal Ganglion Cells | 2006 |
Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model.
Topics: Aged; Aged, 80 and over; Animals; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Female; Glaucoma; Glutamic Acid; Humans; Immunoenzyme Techniques; Intraocular Pressure; Male; Photoreceptor Cells, Vertebrate; Rats; Rats, Inbred BN; Retinal Ganglion Cells | 2006 |
Aloe-emodin metabolites protected N-methyl-d-aspartate-treated retinal ganglion cells by Cu-Zn superoxide dismutase.
Topics: Animals; Anthraquinones; Apoptosis; Chromatography, Liquid; Electrophoresis, Gel, Two-Dimensional; Emodin; Enzyme Inhibitors; Gene Expression Regulation; Glaucoma; Glucuronides; Glutamic Acid; N-Methylaspartate; Neuroprotective Agents; Polymerase Chain Reaction; Protein Processing, Post-Translational; Rats; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells; RNA, Messenger; Spectrometry, Mass, Electrospray Ionization; Sulfates; Superoxide Dismutase; Transcription, Genetic | 2007 |
The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Topics: Amino Acid Transport System X-AG; Animals; Disease Models, Animal; Gene Expression Regulation; Glaucoma; Glutamic Acid; Intraocular Pressure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Nerve Degeneration; Optic Nerve Diseases; Oxidative Stress; Retinal Ganglion Cells; Vision, Ocular | 2007 |
Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons.
Topics: Animals; Apoptosis; Calcium; Caspase 3; Cell Survival; Cells, Cultured; Gene Expression; Glaucoma; Glutamic Acid; Homeostasis; Membrane Potential, Mitochondrial; Muscarinic Agonists; Neuroprotective Agents; Pilocarpine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2008 |
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma.
Topics: Aged; Amino Acids; Animals; Aqueous Humor; Cataract; Cataract Extraction; Disease Models, Animal; Female; Glaucoma; Glutamic Acid; Humans; Macaca fascicularis; Male; Prospective Studies; Rats; Retrospective Studies; Vitrectomy; Vitreous Body | 1996 |
Retinal vulnerability to glutamate excitotoxicity in canine glaucoma: induction of neuronal nitric oxide synthase in retinal ganglion cells.
Topics: Animals; Dogs; Glaucoma; Glutamic Acid; Nitric Oxide Synthase; Retinal Ganglion Cells; Vitreous Body | 1998 |
Characterization of a transformed rat retinal ganglion cell line.
Topics: Animals; Animals, Newborn; Antibodies, Monoclonal; Antigens, Surface; Apoptosis; Biomarkers; Brain-Derived Neurotrophic Factor; Cell Culture Techniques; Cell Differentiation; Cell Line, Transformed; Culture Media, Serum-Free; DNA-Binding Proteins; Glaucoma; Glial Fibrillary Acidic Protein; Glutamic Acid; GPI-Linked Proteins; In Situ Nick-End Labeling; Nerve Growth Factors; Nerve Tissue Proteins; Neuropeptides; Neuroprotective Agents; Rats; Receptors, GABA-B; Retinal Ganglion Cells; Synaptophysin; Syntaxin 1; Thy-1 Antigens; Transcription Factor Brn-3; Transcription Factor Brn-3C; Transcription Factors | 2001 |
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Amino Acid Sequence; Animals; Cell Death; Glatiramer Acetate; Glaucoma; Glutamic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Myelin Basic Protein; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Ocular Hypertension; Peptides; Rats; Rats, Inbred Lew; Retinal Ganglion Cells; T-Lymphocytes; Vaccination | 2001 |
Private investigations.
Topics: Animals; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Confidentiality; Glaucoma; Glutamic Acid; Guinea Pigs; Haplorhini; Humans; Massachusetts; Memantine; Meniere Disease; National Institutes of Health (U.S.); Neurosciences; Pennsylvania; Research; Scientific Misconduct; United States; United States Food and Drug Administration; United States Office of Research Integrity | 2001 |